Deep 6 AI

Deep 6 AI incorporates AI technologies such as machine learning and natural language processing to match patients with clinical trials. It analyzes structured data (information from medical records in standardized formats and unstructured data), clinical research notes, doctors’ notes, and imaging records. By incorporating unstructured data into the evaluation process, Deep 6 AI claims that it can identify 15%–20% of eligible patients for clinical trials.

Additionally, as of June 2024, the company estimates that it can reduce the time spent by clinical research sites to find patients by 50% and increase the overall patient population by 25%.

Key customers and partnerships

The company’s customer base includes healthcare companies, clinical research organizations, and research sponsors. As of June 2021, its customer base also included Cedars Sinai, MD Anderson, Rutgers, and the Texas Medical Center.

As of June 2024, the platform had helped over 1,000 research facilities with over 30 million patients with its trial matching software. The company also noted that, as of the same date, it worked with over 25 major healthcare organizations.

In terms of partnerships, Deep 6 AI was working with multiple academic institutions to deploy its solution, including Stamford Health, East Carolina University, and Penn State. Additionally, the company partnered with AWS to strengthen the data privacy and cyber security of its platform when working with different stakeholders for clinical trials.